Attached files

file filename
10-Q - DESERT GATEWAY, INC. FORM 10-Q 05.31.2011 - Travere Therapeutics, Inc.f110706desertgateway10q05312.htm
EX-31 - EXHIBIT 31 CERTIFICATION - Travere Therapeutics, Inc.f110706exhibit31desertgatewa.htm


EXHIBIT 32

 

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

 

In connection with the accompanying Quarterly Report on Form 10-Q of Desert Gateway, Inc., for the quarter ending May 31, 2011, I, Robert Wilson, Chief Executive Officer and Chief Financial Officer, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:


1.

Such quarterly Report on Form 10-Q for the quarter ending May 31, 2011, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


2.

The information contained in such quarterly report on Form 10-Q for the quarter ended May 31, 2011, fairly represents in all material respects, the financial condition and results of operations of Desert Gateway, Inc.


Dated:  July 6, 2011



DESERT GATEWAY, INC.


By:

/s/  Robert Wilson      

Chief Executive Officer and

Chief Financial Officer